Abstract:N-6-methyladenosine (m(6)A) is the most prevalent internal messenger RNA (mRNA) chemical modification in eukaryotes. This methylation has been shown to be reversible in mammals. It is installed by a methyltransferase complex (writers) of METTL3, METTL14, and Wilms' tumor 1-associating protein (WTAP) and can be removed by demethylases (erasers) FTO and ALKBH5, which are iron(II)- and a-ketoglutarate-dependent dioxygenases. The reversible and dynamic methylation exhibits significant functional roles in various biological processes. The m(6)A modification as an RNA mark is recognized by reader proteins, such as YTH domain family proteins. YTHDF2 regulates the stability of the methylated transcripts in cytoplasm; YTHDF1 promotes protein synthesis of the methylated mRNA by interacting with translation machinery. m(6)A as a switch controls the RNA structure to affect RNA-protein interactions for biological regulation. Meanwhile, many m(6)A detection techniques were developed and applied in biology and medicine. The total m(6)A level in mRNA can be determined by ultra-performance liquid chromatography coupled with triple-quadrupole tandem mass spectrometry (UPLC-QQQ-MS/MS), two-dimensional thin-layer chromatography (2-D TLC), and dot blot. The m(6)A antibody affinity sequencing (MeRIP-seq) was developed to map the m(6)A site location in a transcriptome-wide manner. The single-base resolution methods for single gene or whole transcripts were also invented.

<i>N</i><SUP>6</SUP>-methyladenosine as a Novel Regulator of Brain Physiology and Diseases

N 6 -methyladenosine as a Novel Regulator of Brain Physiology and Diseases

Rna N-6-Methyladenosine Methylation In Post-Transcriptional Gene Expression Regulation

N1-methyladenosine Formation, Gene Regulation, Biological Functions, and Clinical Relevance

The emerging roles of N6-methyladenosine RNA methylation in human cancers

m6A methylation: Critical roles in aging and neurological diseases

N6-methyladenosine-mediated Gene Regulation and Therapeutic Implications.

Dynamic and reversible RNA N6‐methyladenosine methylation

m6A modification and its role in neural development and neurological diseases

<i>N</i><SUP>6</SUP>-methyladenosine RNA methylation: A novel regulator of the development and function of immune cells

N6-methyladenosine and Neurological Diseases

Emerging Roles for DNA 6ma and RNA M6a Methylation in Mammalian Genome

The role of m<SUP>6</SUP>A modification in physiology and disease

RNA epigenetic modification: N6-methyladenosine

N6-methyladenosine modifications: interactions with novel RNA-binding proteins and roles in signal transduction.

m6A RNA methylation in brain injury and neurodegenerative disease

N6‐methyladenosine RNA Methylation: A Novel Regulator of the Development and Function of Immune Cells

Rna Modification N-6-Methyladenosine in Post-Transcriptional Regulation

RNA N6-methyladenosine in nonocular and ocular disease

The Role and Regulatory Mechanism of M6a Methylation in the Nervous System

N6-methyladenosine (m6A) modification and its clinical relevance in cognitive dysfunctions